Deutsch
English
Русский

Frauenklinik und Poliklinik
Josef-Schneider-Str. 4, Haus C15
D-97080 Würzburg

Link zur Babygalerie
Logo Zertifiziertes Gynäkologisches Krebszentrum
Logo Zertifiziertes Brustzentrum
Logo Endometriosezentrum
Dr. med. Joachim Diessner

Dr. med. Joachim Diessner

 

Telefon: +49 (0931) 201-25621

Fax: +49 (0931) 201-25406

e-Mail:  diessner_j@ukw.de

  • Seit 09/2009 Assistenzarzt
  • Seit 06/2015 Facharzt
  • Kolposkopiediplom nach AGCP
  • AGUB Stufe I
  • DEGUM I  Sonographie  Mammasonographie
  • DEGUM I  Sonographie  Pränataldiagnostik
  • GCP-Prüfarzt
  • Hygienebeauftragter Arzt
  • Medikamentöse Tumortherapie
  • Fachspezifische humangenetische Beratung

 

Publikationen

  • Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.  Diessner J, Wischnewsky M, Blettner M, Häusler S, Janni W, Kreienberg R, Stein R, Stüber T, Schwentner L, Bartmann C, Wöckel A. PLoS One. 2016 Dec 19;11(12):e0168730.
    doi: 10.1371/journal.pone.0168730. PMID: 27992550
  • Pattern of Metastatic Spread and Subcategories of Breast Cancer Catharina Bartmann, Manfred Wischnewsky, Tanja Stüber, Roland Stein, Mathias Krockenberger, Sebastian Häusler, Wolfgang Janni, Rolf Kreienberg, Maria Blettner, Lukas Schwentner, Achim Wöckel, Joachim Diessner; Archives of gynecology and obstetrics. 2016. Epub 2016/11/11.
  •  Factors influencing the development of visceral metastasis of breast cancer: a retrospective multi-center study
    Catharina Bartmann and Joachim Diessner, Maria Blettner, Sebastian Häusler, Wolfgang Janni, Rolf Kreienberg, Mathias Krockenberger, Lukas Schwentner, Roland Stein, Tanja Stüber, Achim Wöckel, Manfred Wischnewsky; Breast. 2016;31:66-75. Epub 2016/11/07.
  • Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape.

  • Montalbán Del Barrio I, Penski C, Schlahsa L, Stein RG, Diessner J, Wöckel A, Dietl J, Lutz MB, Mittelbronn M, Wischhusen J, Häusler SF.

  • J Immunother Cancer. 2016 Aug 16;4:49. doi: 10.1186/s40425-016-0154-9. eCollection 2016. PMID: 27532024

  • Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
    Diessner J, Wischnewsky M, Stüber T, Stein R, Krockenberger M, Häusler S, Janni W, Kreienberg R, Blettner M, Schwentner L, Wöckel A, Bartmann C.
    BMC Cancer. 2016 May 12;16:307. doi: 10.1186/s12885-016-2345-7. PMID:27175930
  • Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II.
    Stüber T, van Ewijk R, Diessner J, Kühn T, Flock F, Felberbaum R, Blettner M, Kreienberg R, Janni W, Wöckel A, Singer S, Schwentner L.
    Breast Cancer. 2016 May 19. [Epub ahead of print] PMID:27193566
  • Guidelines are advantageous, though not essential for improved survival among breast cancer patients. Wolters R, Wischhusen J, Stüber T, Weiss CR, Krockberger M, Bartmann C, Blettner M, Janni W, Kreienberg R, Schwentner L, Novopashenny I, Wischnewsky M, Wöckel A, Diessner J. Breast Cancer Res Treat. 2015 Jun 24. PMID:26105798
  • Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study. Diessner J, Van Ewijk R, Weiss CR, Janni W, Wischnewsky MB, Kreienberg R, Hancke K, Blettner M, Wöckel A, Schwentner L. Arch Gynecol Obstet. 2015 Mar 27. PMID:25814296 
  • Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1).Diessner J, Bruttel V, Stein RG, Horn E, Häusler SF, Dietl J, Hönig A, Wischhusen J. Cell Death Dis. 2014 Mar 27;5:e1149. doi: 10.1038/cddis.2014.115. PMID: 24675467 [PubMed - in process]
  • Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Häusler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Hönig A, Dietl J, Wischhusen J. Am J Transl Res. 2014 Jan 15;6(2):129-39. eCollection 2014.PMID: 24489992 [PubMed] Free PMC Article
  • Amniotic fluid insulin and C-peptide as predictive markers for fetal macrosomia, birth injuries, and delivery complications? Stein RG, Meinusch M, Diessner J, Dietl J, Hönig A, Zollner U. Med Sci Monit. 2014 Jan 15;20:54-8. doi: 10.12659/MSM.889503. PMID: 24423633 [PubMed - in process] Free PMC Article
  • XY gonadal dysgenesis--development of a germ cell tumor: case report.Diessner J, Stüber T, Niederle B, Pawlik M, Dietl J, Honig A. Eur J Gynaecol Oncol. 2013;34(6):572-4. PMID: 24601055 [PubMed - in process]
  • Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells. Diessner J, Bruttel V, Becker K, Pawlik M, Stein R, Häusler S, Dietl J, Wischhusen J, Hönig A. Am J Cancer Res. 2013 Apr 3;3(2):211-20. Print 2013.
  • Acute foeto-foetal transfusion syndrome--case report and review of the literature Stein RG, Diessner J, Frieauff E, Zollner U, Rehn M, Dietl J, Hönig A.Z Geburtshilfe Neonatol. 2012 Jun;216(3):147-9. doi: 10.1055/s-0032-1309048. Epub 2012 Jun 21. Review. German.
  • Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells. Engel JB, Hahne JC, Häusler SF, Meyer S, Segerer SE, Diessner J, Dietl J, Honig A. Anticancer Res. 2012 May;32(5):2063-8.
  • PI3K inhibitor D-116883 is effective in in vitro models of ovarian cancer. Honig A, Hahne JC, Meyer S, Kranke P, Häusler S, Diessner J, Dietl J, Engel JB. Anticancer Res. 2012 May;32(5):2035-41.
  • Myocardial infarction in the 34th week of gestation: case report Diessner J, Heuer S, Engel JB, Frambach T, Kranke P, Quaisser C, Dietl J, Honig A. Z Geburtshilfe Neonatol. 2011 Oct;215(5):209-11. doi: 10.1055/s-0031-1271738. Epub 2011 Oct 25. German.
  • <//li><//li><//li>

 

Auszeichnungen:

  • Posterpreis bei der Tagung BGGF und OEGGG Mai 2011, Erlangen
  • Posterpreis bei der Tagung der BGGF 2012 Würzburg
  • Posterpreis bei der Tagung BGGF und OEGGG Mai 2013, Innsbruck
  • Posterpreis beim TraFo Meeting 2016, Düsseldorf